180 related articles for article (PubMed ID: 1692472)
1. Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.
Steward WP; Scarffe JH; Dirix LY; Chang J; Radford JA; Bonnem E; Crowther D
Br J Cancer; 1990 May; 61(5):749-54. PubMed ID: 1692472
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
Steward WP; Scarffe JH; Austin R; Bonnem E; Thatcher N; Morgenstern G; Crowther D
Br J Cancer; 1989 Jan; 59(1):142-5. PubMed ID: 2667607
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
[TBL] [Abstract][Full Text] [Related]
5. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
[TBL] [Abstract][Full Text] [Related]
6. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
7. High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma.
Barlogie B; Jagannath S; Dixon DO; Cheson B; Smallwood L; Hendrickson A; Purvis JD; Bonnem E; Alexanian R
Blood; 1990 Aug; 76(4):677-80. PubMed ID: 2200536
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
[TBL] [Abstract][Full Text] [Related]
9. Growth factor-assisted chemotherapy--the Manchester experience.
Crowther D; Scarffe JH; Howell A; Thatcher N; Bronchud M; Steward WP; Testa N; Dexter M
Ciba Found Symp; 1990; 148():201-10; discussion 211-4. PubMed ID: 1690624
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.
Morstyn G; Campbell L; Lieschke G; Layton JE; Maher D; O'Connor M; Green M; Sheridan W; Vincent M; Alton K
J Clin Oncol; 1989 Oct; 7(10):1554-62. PubMed ID: 2789274
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.
Morstyn G; Campbell L; Souza LM; Alton NK; Keech J; Green M; Sheridan W; Metcalf D; Fox R
Lancet; 1988 Mar; 1(8587):667-72. PubMed ID: 2895212
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
Krigel RL; Palackdharry CS; Padavic K; Haas N; Kilpatrick D; Langer C; Comis R
J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
[TBL] [Abstract][Full Text] [Related]
13. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer.
Hoekman K; Wagstaff J; van Groeningen CJ; Vermorken JB; Boven E; Pinedo HM
J Natl Cancer Inst; 1991 Nov; 83(21):1546-53. PubMed ID: 1960751
[TBL] [Abstract][Full Text] [Related]
18. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Vitolo U; Cortellazzo S; Liberati AM; Freilone R; Falda M; Bertini M; Botto B; Cinieri S; Levis A; Locatelli F; Lovisone E; Marmont F; Pizzuti M; Rossi A; Viero P; Barbui T; Grignani F; Resegotti L
J Clin Oncol; 1997 Feb; 15(2):491-8. PubMed ID: 9053470
[TBL] [Abstract][Full Text] [Related]
19. Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer.
Osborne CK; Sunderland MC; Neidhart JA; Ravdin PM; Abeloff MD
Ann Oncol; 1994 Jan; 5(1):43-7. PubMed ID: 8172792
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
Hovgaard DJ; Nissen NI
J Clin Oncol; 1992 Mar; 10(3):390-7. PubMed ID: 1740678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]